MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202641050247 A) filed by Dr. Latha Kiran Krishna Rajendran, Bangalore, Karnataka, on April 20, for 'ai-optimized car-t cell engineering platforms for personalized immunotherapy.'
Inventor(s) include Dr. Latha Kiran Krishna Rajendran.
The application for the patent was published on May 1, under issue no. 18/2026.
According to the abstract released by the Intellectual Property India: "Chimeric Antigen Receptor T-cell (CAR-T) therapy represents one of the most transformative breakthroughs in oncological medicine, yet its clinical implementation remains constrained by profound challenges in antigen target selection, CAR construct engineering, T-cell manuf...